Pharmacokinetics of transdermal drug delivery
- PMID: 3928870
- DOI: 10.1002/jps.2600740704
Pharmacokinetics of transdermal drug delivery
Abstract
The pharmacokinetics of drug delivery from transdermal controlled-release devices consisting of (a) a membrane plus a reservoir or (b) a monolithic slab are examined. For the period when the devices act as if the drug reservoir were infinite, simple relationships for the steady-state slope and time lag are derived and studied. An analysis of the time region when depletion of the finite dose is obtained is used to estimate the useful device lifetime. Applications to patch design are discussed.
Similar articles
-
Skin permeability: dermatologic aspects of transdermal drug delivery.Am Heart J. 1984 Jul;108(1):200-6. doi: 10.1016/0002-8703(84)90576-3. Am Heart J. 1984. PMID: 6731278
-
Pharmacokinetic characterisation of transdermal delivery systems.Clin Pharmacokinet. 1994 Feb;26(2):121-34. doi: 10.2165/00003088-199426020-00005. Clin Pharmacokinet. 1994. PMID: 8162656 Review.
-
Transdermal drug delivery and cutaneous metabolism.Xenobiotica. 1987 Mar;17(3):325-43. doi: 10.3109/00498258709043943. Xenobiotica. 1987. PMID: 3107225 Review.
-
Membrane systems: practical applications.Methods Enzymol. 1985;112:504-20. doi: 10.1016/s0076-6879(85)12040-9. Methods Enzymol. 1985. PMID: 4046862
-
Pharmacokinetics of drug permeation through human skin.J Pharm Sci. 1978 Oct;67(10):1370-4. doi: 10.1002/jps.2600671010. J Pharm Sci. 1978. PMID: 702282
Cited by
-
Clinical pharmacokinetics of clonidine.Clin Pharmacokinet. 1988 May;14(5):287-310. doi: 10.2165/00003088-198814050-00002. Clin Pharmacokinet. 1988. PMID: 3293868 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical